A new test developed at CHU Sainte-Justine will enable better management of patients with severe combined immunodeficiency (SCID).
By depositing a saliva sample on a tiny device attached to your smartphone, you could find out in five minutes if you’re infected, say pharmacists at UdeM.
Three weeks after onset, more than 90% of infected people have antibodies that recognize one of the hallmarks of SARS-CoV-2, the S glycoprotein.
Université de Montréal researchers discover how a key cancer mutation activates telomerase, the ‘anti-aging enzyme’ that makes tumour cells immortal.
A cancer vaccine developed by the team headed by IRIC’s Dr. Claude Perreault is voted 2019 Scientific Discovery of the Year by the readers of Québec Science!
An international team led by an UdeM epidemiologist will seek to identify health systems on five continents that are best able to respond to the pandemic.
Quebec institutions are pooling their scientific expertise to develop an extraordinary immunization program using passive plasma to fight the disease.
UdeM researchers are trying to better understand COVID-19 by comparing the immune response of children with that of seniors, whose symptoms are more severe.
With a team of a dozen bioinformaticians, UdeM medical professor Julie Hussin is working on getting a genetic picture of the coronavirus responsible for COVID-19.
Hoping to save front-line medical staff a lot of time, specialists in biomedical chemistry at UdeM and Université Laval work on a new screening test for the virus.